Anika Therapeutics Inc (ANIK)

EBITDA Margin

2.25%

TTM · Period ending:

ANIK logo

ANIK EBITDA Margin

Latest reported2.25%
ANIK TTM EBITDA Margin (-25.00% → 2.25%)
High-resolution chart · PNG

ANIK ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Anika Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
2.2544%
-4.0555%
-3.1715%
25.7916%
-4.0512%
-0.3476%
-0.4222%
-16.3462%
-1.9777%
-2.0335%
-5.6984%
-8.698%
-7.757%
-8.0214%
-2.6274%
-3.902%
-1.7501%
-2.6938%
-2.8168%
-1.4938%
-2.8212%
-3.5059%
-0.7696%
6.191%
17.3119%
29.5273%
36.0091%
41.3036%
39.2124%
38.318%
26.2934%
25.2892%
26.4744%
31.209%
44.1007%
46.9341%
50.3004%
49.4918%
52.5648%
55.6004%
55.351%
55.3873%
53.7883%
52.9509%
52.0218%
54.5336%
62.6475%
62.4717%
62.5416%
59.7624%
49.403%
48.1487%
43.3411%
38.219%
34.4686%
28.3957%
28.1992%
26.0126%
23.1967%
20.3002%
17.0974%
14.192%
15.1239%
17.7061%
18.7051%
20.2478%
20.8528%
15.3777%
14.1834%
12.5745%
12.7934%
14.7653%
17.3822%
20.3893%
24.0227%
22.0157%
22.5142%
23.3211%
21.652%
22.0448%
26.6106%
27.8722%
30.1961%
33.1366%
29.1253%
27.6724%
26.1959%
22.8719%
19.6541%
15.5002%
8.7575%
7.8687%
0.4262%
-7.152%
-17.814%
-28.5162%
-32.1949%
-47.5516%
-52.6225%
-21.8689%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.